All covid testing kit sales are final. (Orders are Non-Cancellable; Item is Non-Returnable and non-refundable)

https://bdveritor.bd.com/en-us

The BD Veritor™ Plus System offers convenient point-of-care testing for SARS-CoV-2*, Influenza A+B, Group A Streptococcus, and respiratory syncytial virus and combines rapid, reliable results with ease of implementation and simple workflow options.

***Please note: (Test Kit Orders are Non-Cancellable; Item is Non-Returnable and non-refundable)

BD Veritor™ Plus System

The new wireless BD Veritor™ Plus System provides lab-quality immunoassay test results within minutes. This fast and accurate solution streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. BD Veritor™ Plus System can help detect infectious diseases, such as influenza A and B, respiratory syncytial virus (RSV), and group A strep while the patient is still on site, which can enable faster decision-making for an earlier intervention opportunity.

• Faster access to test results: Help inform appropriate and targeted treatment decisions

• Improved workflow: The BD Veritor™Plus Analyzer improves workflow with an Analyze Now or Walk Away mode, providing test results (with a print-enabled function) and aiding in decision-making while the patient is on site

• Improved traceability: The BD Veritor™ InfoScan module can scan 3 different identifiers (operator ID, specimen ID, and test kit/lot) that can be locally recorded, printed, or downloaded, and reduces hands-on time through automated documentation

• Modularity: Provides a unique solution to meet each testing site's preference Connectivity: BD Veritor™ InfoSync module provides the same benefits as BD Veritor™ InfoScan. Connects and documents tests results across multiple sites and can integrate with a hospital's electronic medical record or laboratory information system

• Advanced particle technology: Enhances sensitivity by using a proprietary process to produce highly stable, modified colloidal metal particles.

• Adaptive read technology: Compensates for background. Nonspecific binding helps improve specificity to reduce false positive results